Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-0711
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii? ; volume:15 ; number:1 ; day:24 ; month:2 ; year:2016 ; pages:1-6 ; date:12.2016
Annals of clinical microbiology and antimicrobials ; 15, Heft 1 (24.2.2016), 1-6, 12.2016
- Urheber
-
Demirdal, Tuna
- Beteiligte Personen und Organisationen
-
Sari, Ummu Sena
Nemli, Salih Atakan
SpringerLink (Online service)
- DOI
-
10.1186/s12941-016-0123-7
- URN
-
urn:nbn:de:1111-201602254246
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Demirdal, Tuna
- Sari, Ummu Sena
- Nemli, Salih Atakan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Colistin Therapy in a 23-Week Gestational-Age Neonate with Multidrug-Resistant Acinetobacter baumannii Pneumonia
Acinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in non-ventilated than ventilated patients?
Efficacy of adjunctive inhaled colistin and tobramycin for ventilator-associated pneumonia: systematic review and meta-analysis
Deep odontogenic infections—identifying risk factors for nosocomial pneumonia
Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis
Microbiological analysis of nosocomial pneumonia at Tanta University Chest Hospital
Update of the treatment of nosocomial pneumonia in the ICU
Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes
Risk factors for progression to bacteremia among patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia in the Intensive Care Unit
Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia
Impact of nosocomial pneumonia on the outcome of mechanically-ventilated patients
Prediction of methicillin-resistant Staphylococcus aureusin patients with non-nosocomial pneumonia
Colistin Therapy in a 23-Week Gestational-Age Neonate with Multidrug-Resistant Acinetobacter baumannii Pneumonia
Acinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in non-ventilated than ventilated patients?
Efficacy of adjunctive inhaled colistin and tobramycin for ventilator-associated pneumonia: systematic review and meta-analysis
Deep odontogenic infections—identifying risk factors for nosocomial pneumonia
Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis
Microbiological analysis of nosocomial pneumonia at Tanta University Chest Hospital
Update of the treatment of nosocomial pneumonia in the ICU
Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes
Risk factors for progression to bacteremia among patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia in the Intensive Care Unit
Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia
Impact of nosocomial pneumonia on the outcome of mechanically-ventilated patients
Prediction of methicillin-resistant Staphylococcus aureusin patients with non-nosocomial pneumonia
Colistin Therapy in a 23-Week Gestational-Age Neonate with Multidrug-Resistant Acinetobacter baumannii Pneumonia
Acinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in non-ventilated than ventilated patients?
Efficacy of adjunctive inhaled colistin and tobramycin for ventilator-associated pneumonia: systematic review and meta-analysis
Deep odontogenic infections—identifying risk factors for nosocomial pneumonia
Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis
Microbiological analysis of nosocomial pneumonia at Tanta University Chest Hospital
Update of the treatment of nosocomial pneumonia in the ICU
Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes
Risk factors for progression to bacteremia among patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia in the Intensive Care Unit
Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia
Impact of nosocomial pneumonia on the outcome of mechanically-ventilated patients